Publication Information

{'id': 'https://openalex.org/W2349558415', 'doi': None, 'title': 'Study on the safety and efficacy of three amino salicylc acid preparations for treating ulcerative colitis', 'display_name': 'Study on the safety and efficacy of three amino salicylc acid preparations for treating ulcerative colitis', 'publication_year': 2014, 'publication_date': '2014-01-01', 'ids': {'openalex': 'https://openalex.org/W2349558415', 'mag': '2349558415'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GYKX201404033.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764707663', 'display_name': 'China Medicine and Pharmacy', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090611750', 'display_name': 'Song Dong-me', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Song Dongme', 'raw_affiliation_strings': ["Department of Gastroenterology, the People's Hospital of Jiawang District in Xuzhou City"], 'affiliations': [{'raw_affiliation_string': "Department of Gastroenterology, the People's Hospital of Jiawang District in Xuzhou City", 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5090611750'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10371', 'display_name': 'Immune Response and Inflammation', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10678', 'display_name': 'Inflammatory mediators and NSAID effects', 'score': 0.9876, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/sulfasalazine', 'display_name': 'Sulfasalazine', 'score': 0.98894906}, {'id': 'https://openalex.org/keywords/mesalazine', 'display_name': 'Mesalazine', 'score': 0.9789944}], 'concepts': [{'id': 'https://openalex.org/C2779383735', 'wikidata': 'https://www.wikidata.org/wiki/Q420035', 'display_name': 'Sulfasalazine', 'level': 4, 'score': 0.98894906}, {'id': 'https://openalex.org/C2779174533', 'wikidata': 'https://www.wikidata.org/wiki/Q412479', 'display_name': 'Mesalazine', 'level': 4, 'score': 0.9789944}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9570652}, {'id': 'https://openalex.org/C2780479503', 'wikidata': 'https://www.wikidata.org/wiki/Q1477', 'display_name': 'Ulcerative colitis', 'level': 3, 'score': 0.95458066}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.72550464}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.68257785}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.6133472}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.56500834}, {'id': 'https://openalex.org/C2775862500', 'wikidata': 'https://www.wikidata.org/wiki/Q2453464', 'display_name': 'Colitis', 'level': 2, 'score': 0.4923333}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.0696179}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GYKX201404033.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764707663', 'display_name': 'China Medicine and Pharmacy', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.7}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3032812622', 'https://openalex.org/W2394173950', 'https://openalex.org/W2392725485', 'https://openalex.org/W2392278512', 'https://openalex.org/W2386497540', 'https://openalex.org/W2385800859', 'https://openalex.org/W2377486882', 'https://openalex.org/W2377180302', 'https://openalex.org/W2372133875', 'https://openalex.org/W2362759457', 'https://openalex.org/W2362333803', 'https://openalex.org/W2361796690', 'https://openalex.org/W2361556633', 'https://openalex.org/W2357716011', 'https://openalex.org/W2353019440', 'https://openalex.org/W2352254143', 'https://openalex.org/W2350497213', 'https://openalex.org/W2350089982', 'https://openalex.org/W2347223478', 'https://openalex.org/W2085520559'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'evaluate': [2], 'the': [3, 37, 43, 70], 'therapeutic': [4], 'effects': [5], 'of': [6, 36, 45, 51, 58, 92, 101], 'mesalazine,': [7], 'osalazine': [8, 26], 'and': [9, 28, 33, 54, 62, 66, 74, 84], 'sulfasalazine': [10, 29, 75, 86], 'for': [11], 'patientswith': [12], 'ulcerative': [13, 19, 93], 'colitis.': [14], 'Methods': [15], '120': [16], 'patients': [17], 'with': [18, 82, 96], 'colitis': [20], 'were': [21, 40, 76], 'randomly': [22], 'divided': [23], 'into': [24], 'mesalazinegroup(n=40),': [25], 'group(n=39)': [27], 'group(n=41).': [30], 'The': [31, 49], 'efficacy': [32], 'adverse': [34, 102], 'events': [35], 'three': [38, 59], 'groups': [39], 'observed': [41], 'after': [42], 'treatment': [44, 91], '12': [46], 'weeks.': [47], 'Results': [48], 'rate': [50, 57], 'complete': [52], 'remission': [53], 'overall': [55], 'effective': [56, 89], 'groupswere30.0%,': [60], '28.2%': [61], '51.2%;': [63], '75.0%,': [64], '76.9%': [65], '92.7%,': [67], 'respectively.': [68], 'And': [69], 'differences': [71], 'between': [72], 'mesalazine/osalazine': [73], 'statistically': [77], 'significant(P': [78], '0.05).': [79], 'Conclusion': [80], 'Compared': [81], 'mesalazine': [83], 'osalazine,': [85], 'is': [87], 'more': [88], 'in': [90], 'colitis,': [94], 'but': [95], 'a': [97], 'relatively': [98], 'higher': [99], 'incidence': [100], 'reactions.': [103]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2349558415', 'counts_by_year': [], 'updated_date': '2024-12-08T16:13:31.683559', 'created_date': '2016-06-24'}